Apraclonidine Interactions

Brand names: Apraclonidine

Route: Ophthalmic

Contraindications

CONTRAINDICATIONS Apraclonidine ophthalmic solution 0.5% is contraindicated in patients with hypersensitivity to apraclonidine or any other component of this medication, as well as systemic clonidine. It is also contraindicated in patients receiving monoamine oxidase (MAO) inhibitors.

Pregnancy & Breastfeeding

Pregnancy Apraclonidine HCl has been shown to have an embryocidal effect in rabbits when given in an oral dose of 3.0 mg/kg (60 times the maximum recommended human dose). Dose related maternal toxicity was observed in pregnant rats at 0.3 mg/kg (6 times the maximum recommended human dose). There are no adequate and well controlled studies in pregnant women. Apraclonidine ophthalmic solution 0.5% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

9 interactions on record

Possibility of additive or potentiating effect with CNS depressants.

Source: NLP:apraclonidine

Caution advised with simultaneous use of clonidine and other similar pharmacologic agents.

Source: NLP:apraclonidine

Apraclonidine may inhibit catecholamine production in response to insulin-induced hypoglycemia and mask hypoglycemia signs.

Source: NLP:apraclonidine

Possibility of additive or potentiating effect with CNS depressants.

Source: NLP:apraclonidine